Next Article in Journal
Basidiospores from Wood-Decay Fungi Transform Laccase Substrates in the Absence of Glucose and Nitrogen Supplements
Previous Article in Journal
Integrated Management of Aphis craccivora in Cowpea Using Intercropping and Entomopathogenic Fungi under Field Conditions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JoF
Volume 6
Issue 2
10.3390/jof6020061
jof-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Diversity of Linear Non-Ribosomal Peptide in Biocontrol Fungi

by
Xiaoyan Niu
1,
Narit Thaochan
2 and
Qiongbo Hu
1,*
1
Key Laboratory of Bio-Pesticide Innovation and Application of Guangdong Province, College of Agriculture, South China Agricultural University, Guangzhou 510642, China
2
Pest Management Biotechnology and Plant Physiology Laboratory, Faculty of Natural Resources, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand
*
Author to whom correspondence should be addressed.
J. Fungi 2020, 6(2), 61; https://doi.org/10.3390/jof6020061
Submission received: 13 March 2020 / Revised: 27 April 2020 / Accepted: 9 May 2020 / Published: 12 May 2020
Browse Figures
Review Reports Versions Notes

Abstract

:
Biocontrol fungi (BFs) play a key role in regulation of pest populations. BFs produce multiple non-ribosomal peptides (NRPs) and other secondary metabolites that interact with pests, plants and microorganisms. NRPs—including linear and cyclic peptides (L-NRPs and C-NRPs)—are small peptides frequently containing special amino acids and other organic acids. They are biosynthesized in fungi through non-ribosomal peptide synthases (NRPSs). Compared with C-NRPs, L-NRPs have simpler structures, with only a linear chain and biosynthesis without cyclization. BFs mainly include entomopathogenic and mycoparasitic fungi, that are used to control insect pests and phytopathogens in fields, respectively. NRPs play an important role of in the interactions of BFs with insects or phytopathogens. On the other hand, the residues of NRPs may contaminate food through BFs activities in the environment. In recent decades, C-NRPs in BFs have been thoroughly reviewed. However, L-NRPs are rarely investigated. In order to better understand the species and potential problems of L-NRPs in BFs, this review lists the L-NRPs from entomopathogenic and mycoparasitic fungi, summarizes their sources, structures, activities and biosynthesis, and details risks and utilization prospects.

1. Introduction

Biocontrol fungi (BFs) play an important role in the control of agricultural and forestry pests. BFs include mainly entomopathogenic and mycoparasitic fungi (EFs and MFs). Entomopathogenic fungi are used extensively in agricultural and medical areas. Beauveria bassiana and Metarhizium anisopliae have been developed as commercial BFs to manage many insect pests worldwide; Cordyceps spp. have been used in traditional medicines in Asia for many years [1,2]. Mycoparasitic fungi such as Trichoderma spp. have been used to control soil-borne plant diseases at commercial scales [3,4]. BFs produce multiple secondary metabolites to interact with pests, plants and microorganisms for better adapting to their environments.
Secondary metabolites produced by BFs mainly include polyketides (PKs), terpenes and non-ribosomal peptides (NRPs). NRPs are synthesized by multidomain mega-enzymes named nonribosmal peptide synthetases (NRPSs), without ribosomes and messenger RNAs. NRPSs assemble numerous NRPs with large structural and functional diversity, including more than 20 marketed drugs with antibacterial (penicillin, vancomycin), antitumor (bleomycin) and immunosuppressant (cyclosporine) activities [5]. Apart from the 20 protein amino acids, NRPs also contain rare amino acids and other organic acids. The N-terminal of NPRs are often modified by fatty acids, heterocyclic compounds, glycosylated or phosphorylated structures [6]. NRPs are divided into linear (L-NRPs) and cyclic NRPs (C-NRPs). Due to lack of cyclization, L-NRPs have peptide chains composed of multiple amino acids often modified by different fat chains or non-protein amino acids. L-NRPs have antimicrobial, insecticidal, antiviral or anticancer properties. There are numerous studies and reviews on fungal non-ribosomal synthases and cyclic peptides [7,8,9]. However, little attention has been paid to L-NRPs from BFs. As the agricultural and medical importance of BFs, it is necessary to investigate the BFs L-NRPs source species, structure, activity and biosynthesis, as well as their potential risks.

2. L-NRPs from Entomopathogenic Fungi

There are more than 1000 species of EFs, mainly belonging to the order Hypocreales. However, only seven L-NRPs have been reported in a few species of the genera, Cordyceps, Paecilomyces, Metarhizium and Hirsutella.

2.1. Cicadapeptins

Cicadapeptins are obtained from Cordyceps heteropoda ARSEF1880 [10]. There are two analogs of cicadapeptins with a modified N-terminal hydroxyproline (Hyp) acylated by n-decanoic acid and a C-terminal leucine (Leu) modified by 1,2-diamino-4-methylpentane (Figure 1). The two residues of Aib (alpha-aminoisobutyric acid) in the chain lead to the typical helical structure of cicadapeptins. Moreover, the Hyp came out twice in succession results in the structural change from helical to continuously curved one [11]. Cicadapeptins I and II show inhibitory effects on Gram-positive and negative bacteria [11].

2.2. Hirsutellic Acid A

Hirsutellic acid A (Figure 2) is a tripeptide isolated from Hirsutella sp. BCC 1528. It has non-polar amino acids Ile, Leu and N-methyl-phenylalanine (N-Me-Phe) [12]. Hirsutellic acid A is inhibitory against Plasmodium falciparum K1 with an IC50 of 8 μM [12].

2.3. Leucinostatins

Leucinostatins can be found in Purpureocillium lilacinum (Paecilomyces lilacinus), Metarhizium marquandii (Paecilomyces marquandii) and Acremonium sp. [13,14,15]. About 24 analogs of leucinostatins were isolated and identified (Figure 3; Table 1). Leucinostatins have different biologic activities, such as antibacterial, antifungal, cytotoxic and phytotoxic properties with inhibition of oxidative phosphorylation and ATP synthesis [16]. Leucinostatins have higher activity against nematodes with LD50 of 10 mg/L [17]. Leucinostatin A inhibits the growth of prostate cancer cells by hindering insulin-like growth factor-I expression [18]. Leucinostatins also have inhibitory effects on plant parasitic oomycetes (Phytophthora spp.) [13].

2.4. Efrapeptins

Efrapeptins are mainly produced by Tolypocladium niveum (Tolypocladium inflatum, Beauveria nivea) and Tolypocladium geodes [19,20,21] but are also found in Acremonium sp. and Metarhizium anisopliae [20,22]. Efrapeptins have 10 analogs with molecular weight of 1592–1676 Da [22]. The analogs of efrapeptins contain alpha–azide carboxylic acid (Figure 4, Table 2). Efrapeptins have antifungal, antimalarial, insecticidal and antitumor activities [20,23]. In particular, they can inhibit the ATPase and, disturb the interaction between ATPase and heat shock protein 90 (Hsp90) [24,25,26]. Actually, not only the F1-ATPase, but also the vacuolar ATPase (V-ATPase) in brush border membrane vesicles (BBMV) can be inhibited [27]. Efrapeptin J inhibit gastric cancer cells HT1080 [28].

2.5. Peptaibol Compounds

Peptaibols are a special kind of L-NRPs which have been found in a variety of soil fungi. Most of them are found in Trichoderma spp. which have been used to control plant disease [29]. To date, more than 500 peptaibols have been identified [30] and among them, 35 types were identified after 2000 [31]. Peptaibols are rich in non-protein amino acid and are often acetylated at the N-terminus and hydroxylated at the C-terminus. Peptaibols contain 5–20 aa residues forming α-helical conformation [32,33]. Moreover, peptaibols form ion channels on the lipid bilayer membrane. Those peptaibols with long sequences (12–20 aa) have the "barrel–stave" ion channel, while, the others with short sequences (5–11 aa) possess the "carpet" ion channel as a dimers with their N-termini connected (Figure 5) [34]. Therefore, peptaibols can break the ion balance of cells leading to functional disorder of cell. They not only have antibacterial, cytotoxic activity, but also are teratogenic to the larvae of some marine organisms [35,36]. In BFs, there are three peptaibols reported.

2.5.1. Culicinins

The entomopathogenic fungus Culicinomyces clavisporus LL-12I252 [37,38] produces culicinins. They are decapeptides with four analogs (A–D) with the sketch of Bta-Pro-Ahmod-Aib/Ala-Aib/Ala-Amd-Leu-Aib-Leu-Apa-Apae-OH (Figure 6). Culicinin D can selectively inhibit MDA 468 breast cancer cells [38].

2.5.2. LP237

The entomopathogenic fungus Tolypocladium geodes (Beauveria geodes) produces LP237 with three analogs (Table 3) [39,40,41]. The highly helical structure of LP237 and the amphiphilic side chain of amino acids form a “barrel–stave” ion channel on the membrane, the Gln6, Gln7 and Gln10 in the peptide are on the same polar surface of the helix, forming a cavity of the ion channel, resulting in the membrane permeability activity of the peptide [42]. LP237 F8 is cytotoxic to P388D1 mouse leukemia cells and human tumor cells, such as lung cancer A549, ovarian cancer OVCAR3, colon cancer SW620 and breast cancer MCF7. It has synergistic actions with other anticancer peptides [42].

2.5.3. Metanicins

Metanicins are produced by strain CBS 597.80 of Metarhizium. There are four analogs with 20 aa residues and are similar to the peptaibols (longibrachin, trichobrachins, trichokonins) from Trichoderma (Table 4). Metanicins inhibit bacteria with the activity order of Micrococcus lutes > Enterococcus faecalis > Staphylococcus aureus > Bacillus subtilis [43].

3. L-NRPs from Mycoparasitic Fungi

There were 14 L-NRPs found in mycoparasitic fungi mainly in the genus of Trichoderma and Penicillium. Apart from δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine (ACV), the other 13 L-NRPs all belong to peptaibols.

3.1. ACV

ACV is a tripeptide formed by condensation of L-aminoadipic acid, L-cysteine and L-valine (Figure 7). It is a synthetic precursor of the antibiotics penicillin and cephalosporins [44]. ACV was isolated from Penicillium chrysogenum, Cephalosporins acremonium and Aspergillus nidulans. Interestingly, Penicillium chrysogenum is the most important ACV producer, it not only increases plant resistance to pathogens [45], but also has insecticidal activity to Bactrocera oleae [46]. ACV is synthesized by ACV synthase (ACVS) which was from fungi and bacteria [47,48,49].

3.2. Harzianins

Harzianins are named because first, identified in extract of Trichoderma harzianum. T. harzianum not only has a good inhibitory effect on plant pathogens, but also be used to control mosquito pests [50]. To date, there are up to 15 harzianin analogs (Table 5). The HC type contains three kinks formed by the Aib-Pro motifs. The structures are 310-helices, which are embedded in the lipid layer to form a voltage-gated ion channel of the "barrel–stave" type, which increases the hydrophobicity and permeability of the lipid bilayer [51,52]. The PCU4 type are similar to HC, but with shorter chain [53]. Compared to HC type, the HB I is missing an Aib-Pro-Ala [54]. There are two Aib-Pro motifs in the HK VI, also in the 310-helices conformation [55]. The HA V only contains an Aib-Pro, forming the center hinge of Pro’s α-helix structure [56].

3.3. Trichorzins

Trichorzins are 18 aa peptaibols with up to 10 analogs found in T. harzianum and T. virens (Table 6). Trichorzin PAs with six analogs found in T. harzianum show the higher activity against mycoplasma and spiroplasma [57,58]. Three TVB analogs were isolated from T. virens [59]. Trichorzins PAs have a polar C-terminus of tryptophan (Trpol) with affinity to the hydrophilic head of the phospholipid molecule in bilayer membrane, which is important for construction of a voltage-gated ion channel of these “barrel–stave” peptaibols [60].

3.4. Longibrachins

Trichoderma longbrachitum has strong inhibition against the soil-borne phytopathogens, Rhizoctonia solani, Sclerotium rolfsii and Pythium aphanidermatum [61]. In addition, it also has insecticidal and nematocidal activity, respectively against insect Leucinodes orbonalis and Heterodera avenae [62,63].
T. longibrachiatum produces longibrachin (LG), which is a peptaibol with 20 aa residues. Six LG analogs were found. The A series LGs with four analogs (LG A Ⅰ–Ⅳ ) have the neutral Gln at 18th aa residues, while the B series (LG B Ⅱ–Ⅲ) are replaced with acidic Glu (Table 7) [64,65]. The negatively charged side chain Glu of LG B increases the oligomerization level of the ion channel and improves the transportation of substances [66]. LGs result in deformities of Crassostrea gigas larvae and may be neurotoxic to Calliphora vomitoria with an ED50 of 270 mg/kg [64,67]. They are also toxic effect on KB cells (human oral epidermoid cancer cells) [64]. LGs show antibacterial activity against mycoplasma and Gram-positive bacteria. LG AIV also shows a weak inhibition of human pathogenic fungus Aspergillus fumigatus [64,65].

3.5. Trichobrachins

Trichobrachins are purified from T. longibrachiatum and T. parceramosum [68]. There are 11 analogs (Table 8) [68,69]. Trichobrachins inhibit Bacillus subtilis [68].

3.6. Trichogins

Trichogin GA IV is purified from T. longibrachiatum strain M3431. It has a sequence of nOct-Aib-Gly-Leu-Aib-Gly-Gly-Leu-Aib-Gly-Ile- Leuol (Figure 8) [70,71]. Trichogin has a N-terminus of n-octanoic acid and contains four hydrophobic glycine, which lead to a hybrid structure with the 310-helix and the α-helix of trichogen [72,73]. Trichogin has low hemolytic activity and obvious antibacterial activity against methicillin-resistant Staphylococcus aureus [72,74]. Trichogin is also toxic to several human tumor cells (mononuclear HL60 in myelogenous leukemia, HeLa in ovarian sarcoma, A431 in epidermoid cancer and A549 in lung cancer) [73,75].

3.7. Trilongins

Trilongins have 13 analogs with 11 or 20aa residues and are mainly found in T. longibrachiatum and T. atroviride (Table 9) [76,77]. The trilongin A series have 11aa residues with average molecular weight of 1175 Da, while the trilongin B and C series have 20aa residues with 1936–1965 Da. Trilongins are toxic to mammals. They destroy the mitochondria of boar sperm cells, remarkably, the mixtures of long and short sequences trilongins are more toxic [77]. Trilongins form voltage-gated K+/Na+ ion channels, moreover, the combinations of A type with B/C type than the single type have synergistic effect to keep the ion channel open longer [77].

3.8. Trichokonins

Trichoderma koningii and Trichoderma pseudokoningii are common mycoparasitic fungi used to control the fungal phytopathogens of vegetables and fruit trees diseases [78,79]. They can produce trichokonins, which are also found in T. longibrachiatum. Trichokonins have four analogs containing large amounts of Aib and forming a helical conformation with a kink (Pro) (Table 10) [64,80,81]. Trichokonins have a broad antibacterial activity against Gram-positive bacteria, especially to Staphylococcus aureus, even multidrug-resistant Staphylococcus aureus. However, trichokonins have no significant effect on Gram-negative bacteria. In addition, trichokonins are highly toxic to hepatocellular carcinoma cells HepG2, lung cancer cells A549 and gastric cancer cells BGC823, leading then to apoptosis [82]. Tichokonin VI is an L-type Ca2+ agonist on cardiac biofilms [83]. In addition, trichokonins also promote antiviral activity of tobacco by inducing the defense response and systemic resistance of tobacco to tobacco mosaic virus (TMV) infection [80].

3.9. Alamethicins

Trichoderma viride (NRRL 3199), a BF widely distributed in nature and used to control soil-borne plant diseases [84,85], produces alamethicins with two analogs, B30 and B50 (Table 11) [86]. Each analogs has many derivatives with the absences of the N-terminal six residues or the C-terminal phenylalaninol (pheol) or the substitution of Ala of 6th residue with Aib or Gln of 7th and 19th residues with Glu. Alamethicins rich in Aib and have two Pro near the N-terminal and C-terminal, the N-terminal of the molecule forms a stable α-helix and the C-terminal exhibits a variable hydrogen bonding pattern [87]. Alamethicin is often used as a model ion channel for passive diffusion of voltage-gated cation ions [88,89].

3.10. Trichotoxins

Trichotoxins with 18 residues were purified from T. viride and T. asperellum. These compounds are divided into trichotoxin A-40 and A-50 analogs with multiple derivatives (Table 12) [90,91]. The differences among the derivatives are the substitution of Aib/Ala, Gln/Glu and C-terminal Aib/D-Iva and only A-50 contains neutral Gln. Trichotoxins have α-helical conformation and form ion channels similar to alamethicin [90]. They cause hemolysis in human erythrocytes at micromolar concentrations and possess cytotoxic activity against GH(4)C(1) rat pituitary and Neuro-2a mouse neuroblastoma cells [92,93].

3.11. Suzukacillins

Suzukacillins (SZs) are also purified from T. viride [94]. There are two families, suzukacillin A (SZ-A) and suzukacillin B(SZ-B) (Table 13) [94,95]. Suzukacillins exhibit membrane modifying and lysing properties similar to those of alamethicin. Suzukacillins inhibit the growth of Bacillus subtilis, Xanthomonas oryzae, Sarcina lutea, Staphylococcus aureus, Mycobacterium phlei, Streptococcus pyogenes, Corynebacterium diphtheriae, Aspergillus niger, Trichophyton fumigatus and Saccharomyces sake at concentrations of 10 to l00 μg/L. Suzukacillins also have hemolytic properties against human erythrocytes [93].

3.12. Hypomurocins

Hypomurocins have 13 analogs (A and B series) (Table 14) purified from Hypocrea muroiana which is a BF not only inhibiting various plant diseases, but also promoting plant growth [96], excepting hypomurocin B that is found in Trichoderma harzianum [59,97]. Hypomurocin A has mixed helical conformation containing α- and 310-helices, as well as types I and III β-turn structures to link the helical [98,99,100]. Hypomurocin B consists of 18 amino acid residues to form the 310-helical structure rather than by α-helical structure [101]. Hypomurocins inhibit Bacillus subtilis and causes hemolysis of rat erythrocytes, moreover, the activity of hypomurocin B is greater than that of hypomurocin A [96].

3.13. Atroviridins and Neoatroviridins

Atroviridins are 20-residue peptaibols with three analogs (Table 15) [102,103]. Neoatroviridins are 18-residue peptaibols with four analogs (Table 16) [104]. They are all purified from T. atroviride (F80317), which is a BFs with antifungal activity [104,105]. Atroviridins and neoatroviridins have strong antifungal activity against some plant pathogenic fungi, such as Curvavularia inaqualis, Collectotrichum dematium and Fusarium oxysporum, as well as moderate activity against Verticillium dahliae, Aspergillus niger and Cladosporium sp. They can inhibit Bacillus subtilis and Staphylococcus aureus. However, they show no activity against Gram-negative bacteria and yeast [102]. Moreover, they have significant cytotoxicity against human cancer cell lines, such as prostate (PC-3), melanoma (UACC62) and leukemia (K562) with IC50 values of 2–4 μg/mL [102].

3.14. Peptaivirin

Peptaivirins are special peptaibols purified from Trichoderma spp. (KGT142). Peptaivirins have two analogs (Table 17), peptaivirins A and B, which show strong antiviral effects on TMV infection [106]. Peptaivirins are rich in Aib and have an N-terminus of acetylated phenylalanine.

4. Biosynthesis of L-NRPs

Non-ribosomal peptides are synthesized by non-ribosomal peptide synthase (NRPS) with multiple modules in some of the largest enzymes found in nature. The modules consist of different domains with specific catalytic activities. The core domains of NRPS include adenylation domain (A domain, recognizing and adenylating the initiation molecule), thiolation domain (T domain, also known as peptidyl carrier protein domain (PCP)) and condensation domain (C domain, catalyzing the corresponding monomers to bind to the new peptide) [8]. In addition to the infrastructure domains (A, T and C domains), NRPSs probably have epimerization domain (E domain), N-methylation domain (M domain) and others to modify the peptide [104]. Finally, there is a thioesterase domain (TE) in bacteria NRPSs or a similar condensation domain (CT domain) in fungal NRPSs to hydrolyze or cyclize the end of the target polypeptide [107,108].
NRPSs are divided into three categories, namely linear, iterative and nonlinear NRPS (Figure 9). The linear NRPSs take C-A-T as the extension module, and the assembly results in the production of linear NRPs or cyclic NRPs. The iterative NRPS has multiple same modules and results in final product of oligopeptides or cyclic NRPs with the multiple residues of the same amino acids. The nonlinear NRPS has other modules (X) and the order of C-A-T is not necessary. It deviates completely from the standard domain organization leading to unexpected products [109]. L-NRPs are mainly synthesized by linear NRPs [109]. The number of modules determines the length of the peptide. Compared with cyclic NRPs, the main difference is whether initiation substrates in A domain have free hydroxyl and amidogen. After hydrolysis in the TE domain, internal esterification or lactam hydrolysis will occur [6]. The biosynthesis process of L-NRPs in biocontrol fungi is complex and few researches have been published, so we take ACV as an example to illustrate the biosynthesis of L-NRPs.
The PcbAB of ACV synthetase (ACVS) was cloned from P. chrysogenum, it measures 11,500 bp with the open reading frame (ORF) being 11,376 bp and coding for a protein of 3791 aa. The genes, PcbAB, PcbC (encoding cyclase) and PcbDE (encoding penicillin acetyltransferase) form a cluster in the 17 Kb DNA region to drive penicillin biosynthesis [110]. The ACVS genes of Cephalosporins acremonium and Aspergillus nidulans are similar to those of P. chrysogenum, with more than 60% similarity [111,112]. ACVS contains ten domains, three modules (M1, M2 and M3), in which M3 has the special domains E and TE domains to conduct epimerization of L-valine and the hydrolysis of ACV (Figure 10) [113]. During biosynthesis, A domain in modules M1 chooses the suitable substrate L-α-aminoadipic acid to activate and form an aminoacyl-AMP. Then, it combines with hydrosulfonyl of T domain to form aminoacyl-S-carrier complex and transferred to modules M2 and form cysteinyl-aminoacyl-S-carrier complex by combining with the activated cysteinyl-S-carrier. Then, it is transferred to M3 and condensated with the activated valinyl-S-carrier into valinyl-cysteinyl-aminoacyl-S-carrier complex. Finally, through intramolecular nucleophilic attacks in TE domain, the L-NRPs δ-(L-α-amino hexanedioyl)-L-cysteinyl-D-valine (ACV) is produced (Figure 10).

5. Discussion

Although only 22 classes of L-NRPs are found in BFs to date, BFs absolutely have abundant diversity of L-NRPs. First, the BFs L-NRPs have diverse molecular structures, i.e., each class has multiple analogs and numerous derivatives with different configurations and conformations. Second, the BFs L-NRPs have multiple functions because each has diverse bioactivities among of antifungi, antibacteria, antiviruses, insecticides, acaricides, nematicides, herbicides or anticancers. Finally, the BFs L-NRPs have diverse distribution, i.e., one species of BFs has more than one class of L-NRPs, on the other hand, a same L-NRP can exist in different BFs species. For example, Trichoderma harzianum at least has two L-NRPs, harzianins and hypomurocin B, while Trchoderma longibrachiatum produces trichobrachins, trichogins, trilongins and trichokonins. Furthermore, efrapeptins are produced by Tolypocladium niveum, Tolypocladium geodes, Acremonium sp. and Metarhizium anisopliae, while trichokonins can be found in Trichoderma koningii, Trichoderma pseudokoningii and T. longibrachiatum.
Interestingly, more L-NRPs have been found in mycoparasitic fungi than in entomopathogenic fungi, especially in the common entomopathogens, such as Beauveria, Metarhizium and Isaria. The main reason may be related to the L-NRPs characteristics of easy hydrolysis [114]. Insects have many proteases especially in their midguts, so if entomopathogens secrete L-NRPs into insect’s body, they will be hydrolyzed soon. However, C-NRPs are difficult to degradation in insects. On the contrary, mycoparasitic fungi usually live in soil and interact with phytopathogens or other microorganisms—in an environment with less proteases. Therefore, the L-NRPs secreted by mycoparaites may persist for a longer time, which has beneficial influences on surrounding microorganisms. The diversity of NRPs is ensured by NRPS through different organizations of domains and modules. The A domains with various structures can select different substrate amino or fatty acids to provide the diverse composition of peptide chain. Undoubtedly, to adapt environments, BFs must take the least costs to obtain the best NRPS genes. Such, the co-evolution of BFs and these target lives leads to less L-NRPs existing in entomopathogenic fungi than in mycoparasitic fungi.
NRPs as drug resources attract much attention of researchers. BFs L-NRPs have the potential as pesticides and medicines as well. For example, bleomycin has been used to treat cancers [5]. ACV as a precursor compound of penicillin has been concerned for long times [52]. Although NRPs are currently not used in agricultural area, the further studies are valuable. However, the more important is the risks of L-NRPs in BFs. As many L-NRPs are toxic, they can hazard human health and non-target beings once they enter the food chain in the process of agricultural application. Although NRPs produced by BFs have little probability to enter food chain [2,9,115], caution must be exercised. It is necessary that adequate risk assessments are conducted before using BFs.
In conclusion, there are 22 classes L-NRPs found in BFs currently. They have abundant diversity including various structures, functions and distributions. The NRPSs through different compositions of domains and modules accomplish biosynthesis of deferent L-NRPs. Mycoparasitic fungi than entomopathogenic fungi produce more L-NRPs, it is maybe because the co-evolutions of fungi with their hosts lead to NRPSs in these two fungi. BFs L-NRPs have the potential as pesticides and medicines. However, the risks of L-NRPs contaminating foods and environment need be paid more attentions.

Author Contributions

X.N. wrote the study. N.T. revised the MS. Q.H. wrote and revised the MS. All authors have read and agreed to the published version of the manuscript.

Funding

This project was supported by the Key Realm R & D Program of Guangdong Province (2019B020218009).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhang, X.F.; Hu, Q.B.; Weng, Q.F. Secondary metabolites (SMs) of Isaria cicadae and Isaria tenuipes. RSC Adv. 2019, 9, 172–184. [Google Scholar] [CrossRef] [Green Version]
  2. Weng, Q.F.; Zhang, X.F.; Chen, W.; Hu, Q.B. Secondary metabolites and the risks of Isaria fumosorosea and Isaria farinosa. Molecules 2019, 24, 664. [Google Scholar] [CrossRef] [Green Version]
  3. Marian, M.; Shimizu, M. Improving performance of microbial biocontrol agents against plant diseases. J. Gen. Plant Pathol. 2019, 85, 329–336. [Google Scholar] [CrossRef]
  4. Silva, R.N.; Monteiro, V.N.; Steindorff, A.S.; Gomes, E.V.; Noronha, E.F.; Ulhoa, C.J. Trichoderma/pathogen/plant interaction in pre-harvest food security. Fungal Biol. 2019, 123, 565–583. [Google Scholar] [CrossRef] [PubMed]
  5. Süssmuth, R.D.; Mainz, A. Nonribosomal peptide synthesis-principles and prospects. Angew. Chem. Int. Ed. Engl. 2017, 56, 3770–3821. [Google Scholar] [CrossRef]
  6. Xue, G.; Stuart, W.H.; Brian, D.A.; Peng, W.; Linda, P.V.; Christopher, T.W.; Yi, T. Cyclization of fungal nonribosomal peptides by a terminal condensation-like domain. Nat. Chem. Biol. 2012, 8, 823–830. [Google Scholar]
  7. Matthias, S.; Alan, T.; Mohamed, A.M. Nonribosomal peptide synthetases: Structures and dynamics. Curr. Opin. Struct. Biol. 2010, 20, 234–240. [Google Scholar]
  8. Bradley, R.M.; Andrew, M.G. Structural biology of nonribosomal peptide synthetases. Methods Mol. Biol. 2016, 1401, 3–29. [Google Scholar]
  9. Hu, Q.; Dong, T. Chapter 8 Non-ribosomal Peptides from Entomogenous Fungi. In Biocontrol of Lepidoperan Pests—Use of Soil Microbes and their Metabolites; Sree, K.S., Varma, A., Eds.; Springer: Cham, Switzerland, 2015; Volume 43, pp. 169–206. [Google Scholar] [CrossRef]
  10. Krasnoff, S.B.; Reategui, R.F.; Wagenaar, M.M.; Gloer, J.B.; Gibson, D.M. Cicadapeptins I and II: New aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda. J. Nat. Prod. 2005, 68, 50–55. [Google Scholar] [CrossRef]
  11. Molnár, I.; Gibson, D.M.; Krasnoff, S.B. Secondary metabolites from entomopathogenic Hypocrealean fungi. Nat. Prod. Rep. 2010, 27, 1241–1275. [Google Scholar] [CrossRef]
  12. Thongtan, J.; Saenboonrueng, J.; Rachtawee, P.; Isaka, M. An antimalarial tetrapeptide from the entomopathogenic fungus Hirsutella sp. BCC 1528. J. Nat. Prod. 2006, 69, 713–714. [Google Scholar] [CrossRef] [PubMed]
  13. Martinez, A.F.C.; Moraes, L.A.B. Liquid chromatography-tandem mass spectrometry characterization of five new leucinostatins produced by Paecilomyces lilacinus CG—189. J. Antibiot. 2015, 68, 178–184. [Google Scholar] [CrossRef] [PubMed]
  14. Radics, L.; Kajtarperedy, M.; Casinovi, C.G.; Rossi, C.; Ricci, M.; Tuttobello, L. Leucinostatins H and K, two novel peptide antibiotics with tertiary amine-oxide terminal group from Paecilomyces marquandii isolation, structure and biological activity. J. Antibiot. 1987, 40, 714–716. [Google Scholar] [PubMed] [Green Version]
  15. Strobel, G.A.; Torczynski, R.; Bollon, A. Acremonium sp.: A leucinostatin A producing endophyte of European yew (Taxus baccata). Plant Sci. 1997, 128, 97–108. [Google Scholar]
  16. Shima, A.; Fukushima, K.; Arai, T.; Terada, H. Dual inhibitory effects of the peptide antibiotics leucinostatins on oxidative phosphorylation in mitochondria. Cell Struct. Funct. 1990, 15, 53–58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Park, J.O.; Hargreaves, J.R.; Mcconville, E.J.; Stirling, G.R.; Ghisalberti, E.L.; Sivasithamparam, K. Production of leucinostatins and nematicidal activity of Australian isolates of Paecilomyces lilacinus (Thom) Samson. Lett. Appl. Microbiol. 2010, 38, 271–276. [Google Scholar] [CrossRef]
  18. Manabu, K.; Hiroyuki, I.; Shun-Ichi, O.; Tohru, M.; Isao, M.; Daishiro, I. Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells. Int. J. Cancer 2010, 126, 810–818. [Google Scholar]
  19. Krasnoff, S.B.; Gupta, S. Identification and directed biosynthesis of efrapeptins in the fungus Tolypocladium geodes gams (Deuteromycotina: Hyphomycetes). J. Chem. Ecol. 1991, 17, 1953–1962. [Google Scholar] [CrossRef]
  20. Krasnoff, S.B.; Gupta, S.; Leger, R.J.S.; Renwick, J.A.A.; Roberts, D.W. Antifungal and insecticidal properties of the efrapeptins: Metabolites of the fungus Tolypocladium niveum. J. Invertebr. Pathol. 1991, 58, 180–188. [Google Scholar] [CrossRef]
  21. Meyling, N.V.; Schmidt, N.M.; Eilenberg, J. Occurrence and diversity of fungal entomopathogens in soils of low and high Arctic Greenland. Polar Biol. 2012, 35, 1439–1445. [Google Scholar] [CrossRef]
  22. Boot, C.M.; Amagata, T.; Tenney, K.; Compton, J.E.; Pietraszkiewicz, H.; Valeriote, F.A.; Crews, P. Four classes of structurally unusual peptides from two marine-derived fungi: Structures and bioactivities. Tetrahedron 2007, 63, 9903–9914. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Papathanassiu, A.E.; MacDonald, N.J.; Emlet, D.R.; Hong, A.V. Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo. Cell Stress Chaperon. 2011, 16, 181–193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Abrahams, J.P.; Buchanan, S.K.; Raaij, M.J.V.; Fearnley, I.M.; Walker, J.E. The structure of bovine F1-ATPase complexed with the peptide antibiotic efrapeptin. Proc. Natl. Acad. Sci. USA 1996, 93, 9420–9424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Papathanassiu, A.E.; MacDonald, N.J.; Bencsura, A.; Vu, H.A. F1F0-ATP synthase functions as a co-chaperone of HSP90—Substrate protein complexes. Biochem. Biophys. Res. Commun. 2006, 345, 420–429. [Google Scholar] [CrossRef]
  26. Laurence, H.P. Review: The HSP90 molecular chaperone—An enigmatic ATPase. Biopolymers 2016, 105, 594–607. [Google Scholar]
  27. Bandani, A.R.; Amiri, B.; Butt, T.M.; Gordon-Weeks, R. Effects of efrapeptin and destruxin, metabolites of entomogenous fungi, on the hydrolytic activity of a vacuolar type ATPase identified on the brush border membrane vesicles of Galleria mellonella midgut and on plant membrane bound hydrolytic enzymes. BBA Biomembranes 2001, 1510, 367–377. [Google Scholar] [CrossRef] [Green Version]
  28. Yoichi, H.; Yuki, H.; Takashi, K.; Kaneo, K.; Kyoko, A.; Yoshikazu, S.; Kazuo, S.Y. Efrapeptin J, a new down-regulator of the molecular chaperone GRP78 from a marine Tolypocladium sp. J. Antibiot. 2008, 61, 365–371. [Google Scholar]
  29. Szekeres, A.; Leiteb, B.; Kredics, L.; Antal, Z.; Hatvani, L.; Manczinger, L.; Vágvölgyi, C. Peptaibols and related peptaibiotics of Trichoderma. Acta Microbiol. Immunol. Hung. 2005, 52, 137–168. [Google Scholar] [CrossRef]
  30. Wang, Z.; Wang, G.S. APD: The antimicrobial peptide database. Nucleic Acids Res. 2004, 32, 590–592. [Google Scholar] [CrossRef] [Green Version]
  31. Zhao, P.; Xue, Y.; Li, X.; Li, J.; Zhao, Z.; Quan, C.; Gao, W.; Zu, X.; Bai, X.; Feng, S. Fungi-derived lipopeptide antibiotics developed since 2000. Peptides 2019, 113, 52–65. [Google Scholar] [CrossRef]
  32. Higashimoto, Y.; Kodama, H.; Jelokhani-Niaraki, M.; Kato, F.; Kondo, M. Structure-function relationship of model Aib-containing peptides as ion transfer intermembrane templates. J. Biochem. 1999, 125, 705–712. [Google Scholar] [CrossRef]
  33. Miick, S.M.; Martinez, G.V.; Fiori, W.R.; Todd, A.P.; Millhauser, G.L. Short alanine-based peptides may form 310-helices and not α-helices in aqueous solution. Nature 1992, 359, 653–655. [Google Scholar] [CrossRef] [PubMed]
  34. Chugh, J.K.; Wallace, B.A. Peptaibols: Models for ion channels. Biochem. Soc. Trans. 2001, 29, 565–570. [Google Scholar] [CrossRef] [PubMed]
  35. Poirier, L.; Quiniou, F.; Ruiz, N.; Montagu, M.; Amiard, J.C.; Pouchus, Y.F. Toxicity assessment of peptaibols and contaminated sediments on Crassostrea gigas embryos. Aquat. Toxicol. 2007, 83, 254–262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Peltola, J.; Ritieni, A.; Mikkola, R.; Grigoriev, P.A.; Pócsfalvi, G.; Andersson, M.A.; Salkinojasalonen, M.S. Biological Effects of Trichoderma harzianum Peptaibols on mammalian Cells. Appl. Environ. Microbiol. 2004, 70, 4996–5004. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Unkles, S.E.; Marriott, C.; Kinghorn, J.R.; Panter, C.; Blackwell, A. Efficacy of the entomopathogenic fungus, Culicinomyces clavisporus against larvae of the biting midge, Culicoides nubeculosus (Diptera: Ceratopogonidae). Biocontrol Sci. Technol. 2004, 14, 397–401. [Google Scholar] [CrossRef]
  38. Haiyin, H.; Janso, J.E.; Hui, Y.; Yang; Bernan, V.S.; Lin, S.L.; Ker, Y. Culicinin D, an antitumor peptaibol produced by the fungus Culicinomyces clavisporus, strain LL-12I252. J. Nat. Prod. 2006, 69, 736–741. [Google Scholar]
  39. Kebede, B.; Wrigley, S.K.; Prashar, A.; Rahlff, J.; Wolf, M.; Reinshagen, J.; Gribbon, P.; Imhoff, J.F.; Silber, J.; Labes, A. Establishing the secondary metabolite profile of the marine fungus:Tolypocladium geodes sp. MF458 and subsequent optimisation of bioactive secondary metabolite production. Mar. Drugs 2017, 15, 84. [Google Scholar] [CrossRef] [Green Version]
  40. Tsantrizos, Y.S.; Pischos, S.; Sauriol, F. Structural assignment of the peptide antibiotic LP237-F8, a metabolite of\r, Tolypocladium geodes. J. Org. Chem. 1996, 61, 2118–2121. [Google Scholar] [CrossRef]
  41. Tsantrizos, Y.S.; Pischos, S.; Sauriol, F.; Widden, P. Peptaibol metabolites of Tolypocladium geodes. Can. J. Chem. 1996, 74, 165–172. [Google Scholar] [CrossRef] [Green Version]
  42. Mario, R.; Alessandro, M.; Cristina, P.; Fernando, F.; Stefano, M.; Evaristo, P.; José Antonio, G.; Maria Dolores, D.D.V.; Carlos, C.; Claudio, T. Lipopeptaibol metabolites of tolypocladium geodes: Total synthesis, preferred conformation, and membrane activity. Chem. Eur. J. 2003, 9, 3567–3576. [Google Scholar]
  43. Kimonyo, A.; Brückner, H. Sequences of metanicins, 20-residue peptaibols from the ascomycetous fungus CBS 597.80. Chem. Biodivers. 2013, 10, 813–826. [Google Scholar] [CrossRef] [PubMed]
  44. Tahlan, K.; Moore, M.A.; Jensen, S.E. δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine synthetase (ACVS): Discovery and perspectives. J. Ind. Microbiol. Biotechnol. 2016, 44, 517–524. [Google Scholar] [CrossRef] [PubMed]
  45. Barbara, T.; Andres, B.; Thomas, B.; Urs, G.; Sonia, J.; Christina, R.; Lucius, T. An aqueous extract of the dry mycelium of Penicillium chrysogenum induces resistance in several crops under controlled and field conditions. Eur. J. Plant Pathol. 2006, 114, 185–197. [Google Scholar]
  46. Konstantopoulou, M.A.; Mazomenos, B.E. Evaluation of Beauveria bassiana and B. brongniartii strains and four wild-type fungal species against adults of Bactrocera oleae and Ceratitis capitata. Biocontrol 2005, 50, 293–305. [Google Scholar] [CrossRef]
  47. Etchegaray, A.; Dieckmann, R.; Kennedy, J.; Turner, G.; Von, D.H. ACV synthetase: Expression of amino acid activating domains of the Penicillium chrysogenum enzyme in Aspergillus nidulans. Biochem. Biophys. Res. Commun. 1997, 237, 166–169. [Google Scholar] [CrossRef]
  48. Hoskins, J.A.; O’Callaghan, N.; Queener, S.W.; Cantwell, C.A.; Wood, J.S.; Chen, V.J.; Skatrud, P.L. Gene disruption of the pcb AB gene encoding ACV synthetase in Cephalosporium acremonium. Curr. Genet. 1990, 18, 523–530. [Google Scholar] [CrossRef]
  49. Jensen, S.E.; Westlake, D.W.S.; Bowers, R.J.; Ingold, C.F.; Jouany, M.; Lyubechansky, L.; Wolfe, S. Penicillin formation by cell-free extracts of Streptomyces clavuligerus. Behaviour of aminoadipyl-modified analogs of the natural peptide precursor δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine (ACV). Can. J. Chem. 2011, 62, 2712–2720. [Google Scholar] [CrossRef]
  50. Sundaravadivelan, C.; Padmanabhan, M.N. Effect of mycosynthesized silver nanoparticles from filtrate of Trichoderma harzianum against larvae and pupa of dengue vector Aedes aegypti L. Environ. Sci. Pollut. Res. Int. 2014, 21, 4624–4633. [Google Scholar] [CrossRef]
  51. Lucaciu, M.; Rebuffat, S.; Goulard, C.; Duclohier, H.; Molle, G.; Bodo, B. Interaction of the 14-residue peptaibols, harzianins HC, with lipid bilayers: Permeability modifications and conductance properties. BBA Biomembranes 1997, 1323, 85–96. [Google Scholar] [CrossRef] [Green Version]
  52. Ségalas, I.; Prigent, Y.; Davoust, D.; Bodo, B.; Rebuffat, S. Characterization of a type of β-bend ribbon spiral generated by the repeating (Xaa–Yaa–Aib–Pro) motif: The solution structure of harzianin HC IX, a 14-residue peptaibol forming voltage-dependent ion channels. Biopolymers 1999, 50, 71–85. [Google Scholar] [CrossRef]
  53. Leclerc, G.; Goulard, C.; Bodo, B.; Rebuffat, S. Directed biosynthesis of peptaibol antibiotics in two Trichoderma strains I. fermentation and isolation. J. Antibiot. 1998, 51, 178–183. [Google Scholar] [CrossRef] [Green Version]
  54. Augeven-Bour, I.; Rebuffat, S.; Auvin, C.; Goulard, C.; Bodo, B. Harzianin HB I, an 11-Residue peptaibol from Trichoderma harzianum: Isolation, sequence, solution synthesis and membrane activity. J. Chem. Soc. Perkin Trans. 1997, 1, 1587–1594. [Google Scholar] [CrossRef]
  55. Putzu, M.; Kara, S.; Afonin, S.; Grage, S.L.; Bordessa, A.; Chaume, G.; Brigaud, T.; Ulrich, A.S.; Kubaå, T. Structural behavior of the peptaibol harzianin HK VI in a DMPC bilayer: Insights from MD simulations. Biophys. J. 2017, 112, 2602–2614. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Rebuffat, S.; Duclohier, H.; Auvin-Guette, C.; Molle, G.; Spach, G.; Bodo, B. Membrane-modifying properties of the pore-forming peptaibols saturnisporin SA IV and harzianin HA V. FEMS Microbiol. Lett. 1992, 105, 51–60. [Google Scholar] [CrossRef] [PubMed]
  57. Duval, D. Isolation and sequence analysis of the peptide antibiotics trichorzins PA from Trichoderma harzianum. J. Chem. Soc. Perkin Trans. 1997, 1, 2147–2154. [Google Scholar] [CrossRef]
  58. Béven, L.; Duval, D.; Rebuffat, S.; Riddell, F.G.; Bodo, B.; Wróblewski, H. Membrane permeabilisation and antimycoplasmic activity of the 18-residue peptaibols, trichorzins PA. BBA Biomembranes 1998, 1372, 78–90. [Google Scholar] [CrossRef] [Green Version]
  59. Aric, W.; Darlene, G.; Bi-Wen, X.; Christophe, G.; Sylvie, R.; Ebbole, D.J.; Bernard, B.; Charles, K. Identification of peptaibols from Trichoderma virens and cloning of a peptaibol synthetase. J. Biol. Chem. 2002, 277, 20862–20868. [Google Scholar]
  60. Duval, D.; Cosette, P.; Rebuffat, S.; Duclohier, H.; Bodo, B.; Molle, G. Alamethicin-like behaviour of new 18-residue peptaibols, trichorzins PA. role of the C-terminal amino-alcohol in the ion channel forming activity. BBA Biomembranes 1998, 1369, 309–319. [Google Scholar] [CrossRef] [Green Version]
  61. Sreenivasaprasad, S.; Manibhushanrao, K. Antagonistic potential of Gliocladium virens and Trichoderma longibrachiatum to phytopathogenic fungi. Mycopathologia 1990, 109, 19–26. [Google Scholar] [CrossRef]
  62. Ghosh, S.K.; Pal, S. Entomopathogenic potential of Trichoderma longibrachiatum and its comparative evaluation with malathion against the insect pest Leucinodes orbonalis. Environ. Monit. Assess. 2016, 188, 37. [Google Scholar] [CrossRef] [PubMed]
  63. Zhang, S.W.; Gan, Y.T.; Xu, B.L. Efficacy of Trichoderma longibrachiatum in the control of Heterodera avenae. Biocontrol 2014, 59, 319–331. [Google Scholar] [CrossRef]
  64. Mohamed-Benkada, M.; Pouchus, Y.F.; Vérité, P.; Pagniez, F.; Caroff, N.; Ruiz, N. Identification and biological activities of long-chain peptaibols produced by a marine-derived strain of Trichoderma longibrachiatum. Chem. Biodivers. 2016, 13, 521–530. [Google Scholar] [CrossRef] [PubMed]
  65. Leclerc, G. Sequences and antimycoplasmic properties of longibrachins LGB II and LGB III, two novel 20-residue peptaibols from Trichoderma longibrachiatum. J. Nat. Prod. 2001, 64, 164–170. [Google Scholar] [CrossRef]
  66. Cosette, P.; Rebuffat, S.; Bodo, B.; Molle, G. The ion-channel activity of longibrachins LGA I and LGB II: Effects of pro-2/Ala and gln-18/Glu substitutions on the alamethicin voltage-gated membrane channels. BBA Biomembranes 1999, 1461, 113–122. [Google Scholar] [CrossRef] [Green Version]
  67. Nicolas, R.; Karina, P.; Marieke, V.; Isabelle, K.; Joseph, B.; Zouher, A.; Jean-François, B.; Olivier, G.; Yves François, P. Enhancement of domoic acid neurotoxicity on Diptera larvae bioassay by marine fungal metabolites. Toxicon 2010, 55, 805–810. [Google Scholar]
  68. Krause, C.; Kirschbaum, J.; Brückner, H. Peptaibiomics: Microheterogeneity, dynamics, and sequences of trichobrachins, peptaibiotics from Trichoderma parceramosum Bissett (T. longibrachiatum Rifai). Chem. Biodivers. 2010, 38, 1083–1102. [Google Scholar] [CrossRef]
  69. Mustapha, M.B.; Monique, M.; Jean-François, B.; Florence, M.; Philippe, V.; Michèle, D.; John, B.; Yves François, P. New short peptaibols from a marine Trichoderma strain. Rapid Commun. Mass Spectrom. 2006, 20, 1176–1180. [Google Scholar]
  70. Auvin-Guette, C.; Rebuffat, S.; Prigent, Y.; Bodo, B. Trichogin A IV, an 11-residue lipopeptaibol from Trichoderma longibrachiatum. J. Am. Chem. Soc. 1992, 114, 2170–2174. [Google Scholar] [CrossRef]
  71. Salnikov, E.S.; Zotti, M.D.; Bobone, S.; Mazzuca, C.; Bechinger, B. Trichogin GA IV alignment and oligomerization in phospholipid bilayers. ChemBioChem 2019, 20, 2141–2150. [Google Scholar] [CrossRef] [Green Version]
  72. Toniolo, C.; Crisma, M.; Formaggio, F.; Peggion, C.; Epand, R.F.; Epand, R.M. Lipopeptaibols, a novel family of membrane active, antimicrobial peptides. Cell. Mol. Life Sci. 2001, 58, 1179–1188. [Google Scholar] [CrossRef] [PubMed]
  73. De, Z.M.; Biondi, B.; Peggion, C.; Formaggio, F.; Park, Y.; Hahm, K.S.; Toniolo, C. Trichogin GA IV: A versatile template for the synthesis of novel peptaibiotics. Org. Biomol. Chem. 2012, 10, 1285–1299. [Google Scholar]
  74. Marta, D.Z.; Barbara, B.; Fernando, F.; Claudio, T.; Lorenzo, S.; Yoonkyung, P.; Kyung-Soo, H. Trichogin GA IV: An antibacterial and protease-resistant peptide. J. Pept. Sci. 2010, 15, 615–619. [Google Scholar]
  75. Regina, T.; Giulia, M.; Marta, D.Z.; Cristina, P.; Barbara, B.; Fernando, F.; Emanuele, P. The peculiar N- and C-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity. BBA Biomembranes 2015, 1848, 134–144. [Google Scholar]
  76. Röhrich, C.R.; Iversen, A.; Jaklitsch, W.M.; Voglmayr, H.; Vilcinskas, A.; Nielsen, K.F.; Thrane, U.; Von, D.H.; Brückner, H.; Degenkolb, T. Screening the biosphere: The fungicolous fungus Trichoderma phellinicola, a prolific source of hypophellins, new 17-, 18-, 19-, and 20-residue peptaibiotics. Chem. Biodivers. 2013, 10, 787–812. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Mikkola, R.; Andersson, M.A.; Kredics, L.; Grigoriev, P.A.; Sundell, N.; Salkinoja-Salonen, M.S. 20-Residue and 11-residue peptaibols from the fungus Trichoderma longibrachiatum are synergistic in forming Na+/K+ -permeable channels and adverse action towards mammalian cells. FEBS J. 2012, 279, 4172–4190. [Google Scholar] [CrossRef] [PubMed]
  78. Metcalf, D.A.; Wilson, C.R. The process of antagonism of Sclerotium cepivorum in white rot affected onion roots by Trichoderma koningii. Plant Pathol. 2001, 50, 249–257. [Google Scholar] [CrossRef]
  79. Mukherjee, P.K.; Sherkhane, P.D.; Murthy, N.B. Induction of stable benomyl-tolerant phenotypic mutants of Trichoderma pseudokoningii MTCC 3011, and their evaluation for antagonistic and biocontrol potential. Indian J. Exp. Biol. 1999, 37, 710–712. [Google Scholar]
  80. Luo, Y.; Zhang, D.D.; Dong, X.W.; Zhao, P.B.; Chen, L.L.; Song, X.Y.; Wang, X.J.; Chen, X.L.; Shi, M.; Zhang, Y.Z. Antimicrobial peptaibols induce defense responses and systemic resistance in tobacco against tobacco mosaic virus. FEMS Microbiol. Lett. 2010, 313, 120–126. [Google Scholar] [CrossRef] [Green Version]
  81. Huang, Q.; Tezuka, Y.; Hatanaka, Y.; Kikuchi, T.; Nishi, A.; Tubaki, K. Studies on metabolites of mycoparasitic fungi. IV. Minor peptaibols of Trichoderma koningii. Chem. Pharm. Bull. 1995, 43, 1663–1667. [Google Scholar] [CrossRef] [Green Version]
  82. Song, X.Y.; Shen, Q.T.; Xie, S.T.; Chen, X.L.; Sun, C.Y.; Zhang, Y.Z. Broad-spectrum antimicrobial activity and high stability of trichokonins from Trichoderma koningii SMF2 against plant pathogens. FEMS Microbiol. Lett. 2006, 260, 119–125. [Google Scholar]
  83. Huang, Q.; Tezuka, Y.; Kikuchi, T.; Momose, Y. Trichokonin VI, a new Ca2+ channel agonist in bullfrog cardiac myocytes. Eur. J. Pharmacol. 1994, 271, 5–6. [Google Scholar] [CrossRef]
  84. Ubalua, A.O.; Oti, E. Antagonistic properties of Trichoderma viride on post harvest cassava root rot pathogens. Afr. J. Biotechnol. 2007, 6, 2447–2450. [Google Scholar] [CrossRef] [Green Version]
  85. Naglot, A.; Goswami, S.; Rahman, I.; Shrimali, D.D.; Yadav, K.K.; Gupta, V.K.; Rabha, A.J.; Gogoi, H.K.; Veer, V. Antagonistic potential of native Trichoderma viride Strain against potent tea fungal pathogens in north east India. Plant Pathol. J. 2015, 31, 278–289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Psurek, A.; Neususs, C.; Pelzing, M.; Scriba, G.K.E. Analysis of the lipophilic peptaibol alamethicin by nonaqueous capillary electrophoresis-electrospray ionization-mass spectrometry. Electrophoresis 2005, 26, 4368–4378. [Google Scholar] [CrossRef]
  87. Cafiso, D.S. Alamethicin: A peptide model for voltage gating and protein-membrane interactions. Ann. Rev. Biophys. 1994, 23, 141–165. [Google Scholar]
  88. Tieleman, D.P.; Berendsen, H.J.C.; Mark, S.P.S. An alamethicin channel in a lipid bilayer: Molecular dynamics simulations. Biophys. J. 1999, 76, 1757–1769. [Google Scholar] [CrossRef] [Green Version]
  89. Matsue, T.; Shiku, H.; Yamada, H.; Uchida, I. Permselectivity of voltage-gated alamethicin ion channel studied by microamperometry. J. Phys. Chem. C 2002, 98, 394–402. [Google Scholar] [CrossRef]
  90. Chugh, J.K.; Brückner, H.; Wallace, B.A. Model for a helical bundle channel based on the high-resolution crystal structure of trichotoxinA 50E. Biochemistry 2002, 41, 12934–12941. [Google Scholar] [CrossRef]
  91. Chutrakul, C.; Alcocer, M.; Bailey, K.; Peberdy, J.F. The production and characterisation of trichotoxin peptaibols, by Trichoderma asperellum. Chem. Biodivers. 2008, 5, 1694–1706. [Google Scholar] [CrossRef]
  92. Schock, T.B.; Huncik, K.; Beauchesne, K.R.; Villareal, T.A.; Moeller, P.D. Identification of trichotoxin, a novel chlorinated compound associated with the bloom forming Cyanobacterium, Trichodesmium thiebautii. Environ. Sci. Technol. 2011, 45, 7503–7509. [Google Scholar] [CrossRef] [PubMed]
  93. Duclohier, H.; Alder, G.M.; Bashford, C.L.; Brückner, H.; Chugh, J.K.; Wallace, B.A. Conductance Studies on Trichotoxin_A50E and Implications for Channel Structure. Biophys. J. 2004, 87, 1705–1710. [Google Scholar] [CrossRef] [Green Version]
  94. Krause, C.; Kirschbaum, J.; Jung, G.; Brückner, H. Sequence diversity of the peptaibol antibiotic suzukacillin-A from the mold Trichoderma viride. J. Pept. Sci. 2005, 12, 321–327. [Google Scholar] [CrossRef] [PubMed]
  95. Röhrich, C.R.; Vilcinskas, A.; Brückner, H.; Degenkolb, T. The sequences of the eleven-residue peptaibiotics: Suzukacillins-B. Chem. Biodivers. 2013, 10, 827–837. [Google Scholar] [CrossRef] [PubMed]
  96. Becker, D.; Kiess, M.; Brückner, H. Structures of peptaibol antibiotics hypomurocin A and B from the Ascomycetous fungus Hypocrea muroiana hino et katsumoto. Eur. J. Org. Chem. 1997, 1997, 767–772. [Google Scholar] [CrossRef]
  97. Röhrich, C.R.; Jaklitsch, W.M.; Voglmayr, H.; Iversen, A.; Vilcinskas, A.; Nielsen, K.F.; Thrane, U.; von Döhren, H.; Brückner, H.; Degenkolb, T. Front line defenders of the ecological niche: Screening the structural diversity of peptaibiotics from saprotrophic and fungicolous Trichoderma/Hypocreaspecies. Fungal Divers. 2014, 69, 117–146. [Google Scholar] [CrossRef]
  98. Pradeille, N.; Zerbe, O.; Möhle, K.; Linden, A.; Heimgartner, H. The first total synthesis of the peptaibol hypomurocin A1 and its conformation analysis: An application of the ‘Azirine/Oxazolone Method’. Chem. Biodivers. 2005, 2, 1127–1152. [Google Scholar] [CrossRef]
  99. Pradeille, N.; Tzouros, M.; Möhle, K.; Linden, A.; Heimgartner, H. Total synthesis of the peptaibols hypomurocin A3 and hypomurocin A5, and their conformation analysis. Chem. Biodivers. 2012, 9, 2528–2558. [Google Scholar] [CrossRef]
  100. Zoltán, N.; János, H.; Balázs, L. In silico conformational analysis of the short-sequence hypomurocin A peptides. Int. J. Pept. 2015, 2015, 281065. [Google Scholar] [CrossRef]
  101. Horváth, J.; Násztor, Z.; Bartha, F.; Bogár, F.; Leitgeb, B. Characterizing the structural and folding properties of long-sequence hypomurocin B peptides and their analogs. Biopolymers 2016, 106, 645–657. [Google Scholar] [CrossRef] [Green Version]
  102. Seung-Uk, O.H.; Yun, B.S.; Sang-Jun, L.; Jung-Han, K.; Ick-Han, Y. Atroviridins A~C and neoatroviridins A~D, novel peptaibol antibiotics produced by Trichoderma atroviride F80317 I. taxonomy, fermentation, isolation and biological activities. J. Antibiot. 2002, 55, 211. [Google Scholar]
  103. Oh, S.U.; Lee, S.J.; Kim, J.H.; Yoo, I.-D. Structural elucidation of new antibiotic peptides, atroviridins A, B and C from Trichoderma atroviride. Tetrahedron Lett. 2010, 41, 61–64. [Google Scholar] [CrossRef]
  104. Carver, C.E.; Pitt, D.; Rhodes, D.J. Aetiology and biological control of Fusarium wilt of pinks (Dianthus caryophyllus) using Trichoderma aureoviride. Plant Pathol. 1996, 45, 618–630. [Google Scholar] [CrossRef]
  105. Kandasamy, S.K.; Myeong-Hyeon, W. Isolation and molecular identification of Trichoderma species from wetland soil and their antagonistic activity against phytopathogens. Physiol. Mol. Plant Pathol. 2020, 109, 101458. [Google Scholar] [CrossRef]
  106. Yun, B.S.; Yoo, I.D.; Kim, Y.H.; Kim, Y.S.; Lee, S.J.; Kim, K.S.; Yeo, W.H. Peptaivirins A and B, two new antiviral peptaibols against TMV infection. Tetrahedron Lett. 2000, 41, 1429–1431. [Google Scholar] [CrossRef]
  107. Walsh, C.T.; Chen, H.; Keating, T.A.; Hubbard, B.K.; Losey, H.C.; Luo, L.; Marshall, C.G.; Miller, D.A.; Patel, H.M. Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines. Curr. Opin. Chem. Biol. 2001, 5, 525–534. [Google Scholar] [CrossRef]
  108. Zhang, J.; Liu, N.; Cacho, R.A.; Gong, Z.; Liu, Z.; Qin, W.; Tang, C.; Tang, Y.; Zhou, J. Structural basis of nonribosomal peptide macrocyclization in fungi. Nat. Chem. Biol. 2016, 12, 1001–1003. [Google Scholar] [CrossRef] [Green Version]
  109. Mootz, H.D.; Schwarzer, D.; Marahiel, M.A. Ways of assembling complex natural products on modular nonribosomal peptide synthetases. ChemBioChem 2002, 3, 490–504. [Google Scholar] [CrossRef]
  110. Axel, A.B.; Petra, S.; Qusai, A.A.; Alexander, G.; Hans, P.; André, T. Regulation of penicillin biosynthesis in filamentous fungi. Adv. Biochem. Eng. Biot. 2004, 88, 45–90. [Google Scholar]
  111. Gutierrez, S.; Diez, B.; Montenegro, E.; Martin, J.F. Characterization of the Cephalosporium acremonium pcbAB gene encoding alpha-aminoadipyl-cysteinyl-valine synthetase, a large multidomain peptide synthetase: Linkage to the pcbC gene as a cluster of early cephalosporin biosynthetic genes and evidence of multiple functional domains. J. Bacteriol. 1991, 173, 2354–2365. [Google Scholar]
  112. MacCabe, A.P.; Liempt, H.V.; Palissa, H.; Unkles, S.E.; Riach, M.B.; Pfeifer, E.; Dohren, H.V.; Kinghorn, J.R. Delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase from Aspergillus nidulans. molecular characterization of the acvA gene encoding the first enzyme of the penicillin biosynthetic pathway. J. Biol. Chem. 1991, 266, 12646–12654. [Google Scholar] [PubMed]
  113. Wu, X.; García-Estrada, C.; Vaca, I.; Martín, J.F. Motifs in the C-terminal region of the Penicillium chrysogenum ACV synthetase are essential for valine epimerization and processivity of tripeptide formation. Biochimie 2012, 94, 354–364. [Google Scholar] [CrossRef] [PubMed]
  114. Zompra, A.A.; Galanis, A.S.; Werbitzky, O.; Albericio, F. Manufacturing peptides as active pharmaceutical ingredients. Future Med. Chem. 2009, 1, 361–377. [Google Scholar] [CrossRef] [PubMed]
  115. Zimmermann, G. Review on safety of the entomopathogenic fungi Beauveria bassiana and Beauveria brongniartii. Biocontrol Sci. Technol. 2007, 17, 553–596. [Google Scholar] [CrossRef]
Jof 06 00061 g001 550
Figure 1. Basic structure and analogs of cicadapeptins
Figure 1. Basic structure and analogs of cicadapeptins
Jof 06 00061 g001
Jof 06 00061 g002 550
Figure 2. Structural formula of hirsutellic acid A.
Figure 2. Structural formula of hirsutellic acid A.
Jof 06 00061 g002
Jof 06 00061 g003 550
Figure 3. Basic structure of leucinostatins.
Figure 3. Basic structure of leucinostatins.
Jof 06 00061 g003
Jof 06 00061 g004 550
Figure 4. Basic structure and analogs of efrapeptins.
Figure 4. Basic structure and analogs of efrapeptins.
Jof 06 00061 g004
Jof 06 00061 g005 550
Figure 5. Peptaibols act as ion channels in membrane [34]. (a) “barrel–stave” ion channel model; (b) “carpet” ion channel model.
Figure 5. Peptaibols act as ion channels in membrane [34]. (a) “barrel–stave” ion channel model; (b) “carpet” ion channel model.
Jof 06 00061 g005
Jof 06 00061 g006 550
Figure 6. Basic structure and analogs of culicinins.
Figure 6. Basic structure and analogs of culicinins.
Jof 06 00061 g006
Jof 06 00061 g007 550
Figure 7. Structural formula of δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine.
Figure 7. Structural formula of δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine.
Jof 06 00061 g007
Jof 06 00061 g008 550
Figure 8. Structure of trichogin GA IV.
Figure 8. Structure of trichogin GA IV.
Jof 06 00061 g008
Jof 06 00061 g009 550
Figure 9. Synthesis of non-ribosomal peptide synthases (NRPSs) types. (M1 module is the initial of synthesis, M2 and M3 are the extension; X in nonlinear NRPS represents other domains).
Figure 9. Synthesis of non-ribosomal peptide synthases (NRPSs) types. (M1 module is the initial of synthesis, M2 and M3 are the extension; X in nonlinear NRPS represents other domains).
Jof 06 00061 g009
Jof 06 00061 g010 550
Figure 10. Biosynthesis of ACV.
Figure 10. Biosynthesis of ACV.
Jof 06 00061 g010
Table
Table 1. Analogs of leucinostatins.
Table 1. Analogs of leucinostatins.
LeucinostatinStrainR1R2R3R4Ref.
CP. lilacinus CG-189-CH3-H-H-H[13]
TP. lilacinus CG-189-H-H-H-CH3[13]
FP. lilacinus CG-189-CH3-H-H-CH3[13]
DP. lilacinus CG-189-CH3-H-CH3-CH3[13]
NP. lilacinus CG-189-CH3-OH-H-CH3[13]
H *P. lilacinu CG-189
P. marquandii		-CH3-H\\[13,14]
B2P. lilacinus CG-189-CH3-CH=CHCOCH2CH3-H-CH3[13]
VP. lilacinus CG-189-CH3-CH2CH2COCH2CH3-H-CH3[13]
LP. lilacinus CG-189-H-CH(OH)CH2COCH2CH3-H-CH3[13]
A2P. lilacinus CG-189-CH3-CH=CHCOCH2CH3-CH3-CH3[13]
RP. lilacinus CG-189-CH3-CH2CH2COCH2CH3-CH3-CH3[13]
BP. lilacinus CG-189-CH3-CH(OH)CH2COCH2CH3-H-CH3[13]
SP. lilacinus CG-189-CH3-CH2CH2(OH)CHCH2CH3-CH3-CH3[13]
AP. lilacinus CG-189-CH3-CH(OH)CH2COCH2CH3-CH3-CH3[13]
UP. lilacinus CG-189-CH3-CH(OCH3)CH2COCH2CH3-H-CH3[13]
KP. lilacinus CG-189,
P. marquandii		-CH3-CH(OH)CH2COCH2CH3\\[13,14]
WP. lilacinus CG-189-CH3-(C10H15O3)-H-CH3[13]
QP. lilacinus CG-189-CH3-(C11H17O3)-H-CH3[13]
OP. lilacinus CG-189-CH3-(C11H17O3)-CH3-CH3[13]
ⅠP. lilacinus CG-189-H-CH3-CH3-CH3[13]
ⅡP. lilacinus CG-189-H-H-H-CH3[13]
ⅢP. lilacinus CG-189-H-CH2CH2(OH)CHCH2CH3-CH3-CH3[13]
ⅣP. lilacinus CG-189-CH3-CH2CH2(OH)CHCH2CH3-H-CH3[13]
VP. lilacinus CG-189-H-CH(OH)CH2COCH2CH3-CH3-CH3[13]
* The C- terminal -N(R3)R4 of leucinostatin H is altered with -CH2CH2ONH2.
Table
Table 2. The analogs of efrapeptins.
Table 2. The analogs of efrapeptins.
EfrapeptinStrainRRef.
AT. niveum ARSEF NO.616Ac-Aib-Gly-Leu-Iva-[20]
BT. niveum ARSEF NO.616Ac-Leu-Iva-[20]
CT. niveum ARSEF NO.616,
T. geodes ARSEF 2684		Ac-Pip-Aib-Pip-Aib-Aib-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Gly-Leu-Aib-[19,20]
DT. niveum ARSEF 616,
T. geodes ARSEF 2684,
M. anisopliae ME1		Ac-Pip-Aib-Pip-Aib-Aib-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Gly-Leu-Iva-[19,20]
ET. niveum ARSEF 616,
T. geodes ARSEF 2684		Ac-Pip-Aib-Pip-Iva-Aib-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Gly-Leu-Iva-[19,20]
EαAcremonium sp. 021172cAc-Pip-Aib-Pip-Iva-Aib-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Ala-Leu-Aib-[22]
FT. niveum ARSEF 616,
T. geodes ARSEF 2684,
M. anisopliae ME1		Ac-Pip-Aib-Pip-Aib-Aib-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Ala-Leu-Iva-[19,20]
GT. niveum ARSEF 616,
T. geodes ARSEF 2684		Ac-Pip-Aib-Pip-Iva-Aib-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Ala-Leu-Iva-[19,20]
HT. geodes ARSEF 2684,
Acremonium sp. 021172c		Ac-Pip-Aib-Pip-Iva-Iva-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Ala-Leu-Iva-[19,22]
JTolypocladium sp. AMB18Ac-Pip-Aib-Pip-Aib-Aib-Leu-βAla-Gly-Aib-Aib-Pip-Aib-Ala-Leu-Aib-[28]
Ac: acetyl; Pip: 4-aminopiperidine-4-carboxyl; Iva: S-isovaline; βAla: β-Alanine; Gly: glycine.
Table
Table 3. Analogs of LP237.
Table 3. Analogs of LP237.
LP237Composition
F8nOca-Aib-Pro-Phe-Aib-Gln-Gln-Aib-Et-Nva-Gln-Ala-Leuol
F5nOca-Aib-Pro-Tyr-Aib-Gln-Gln-Aib-Et-Nva-Gln-Ala-Leuol
F7nDec-Aib-Pro-Phe-Aib-Gln-Gln-Aib-Aib-Gln-Ala-Leuol
Leuol: Leucinol; Et-Nva: 2-amino-3-ethylpentanoic acid; Tyr: Tyrosine.
Table
Table 4. Analogs of metanicins.
Table 4. Analogs of metanicins.
MetanicinsComposition
AAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln-Gln-Pheol
BAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-D-Iva-Gln-Gln- Pheol
CAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln-Gln-Pheol
DAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-D-Iva-Gln-Gln-Pheol
Pheol: Phenylalaninol.
Table
Table 5. Analogs of harzianins.
Table 5. Analogs of harzianins.
HarzianinResidueAnalogsStrainCompositionRef.
HC1411T. harzianum M-903603Ac-Aib-Gln/Asn-Leu-Aib-Pro-Ala/Ser-Ile/Val-Aib-Pro-Iva/Aib-Leu-Aib-Pro-Leuol[51]
HB I111T. harzianum M-903603Ac-Aib-Asn-Leu-Ile-Aib-Pro-Iva-Leu-Aib-Pro-Leuol[54]
HK VI111Trichoderma sp.Ac-Aib-Asn-Ile-Ile-Aib-Pro-Leu-Leu-Aib-Pro-Leuol[55]
HA V181T. harzianum M-903603Ac-Aib-Gly-Ala-Aib-Iva-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Iva-Gln-Leuol[56]
PCU4141T. harzianumAc-Aib-Asn-Leu-Aib-Pro-Ser-Ile-Aib-Pro-Aib-Leu-Aib-Pro-Valinol[53]
Table
Table 6. Analogs of trichorzins.
Table 6. Analogs of trichorzins.
TrichorzinStrainCompositionRef.
PA IIT. harzianum M-902608Ac-Aib-Ser-Ala-Aib-Iva-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Trpol[57]
PA IVT. harzianum M-902608Ac-Aib-Ser-Ala-Aib-Iva-Gln-Iva-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Trpol[57]
PA VT. harzianum M-902608Ac-Aib-Ser-Ala-Iva-Iva-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Trpol[57]
PA VIT. harzianum M-902608Ac-Aib-Ser-Ala-Aib-Iva-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Pheol[57]
PA VIIIT. Harzianum M-902608)Ac-Aib-Ser-Ala-Aib-Iva-Gln-Iva-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Pheol[57]
PA IXT. harzianum M-902608Ac-Aib-Ser-Ala-Iva-Iva-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Pheol[57]
PAU4T. harzianum M-902608Ac-Aib-Ser-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Trpol[57]
TVB IT. virens TV29–8Ac-Aib-Gly-Ala-Val-Aib-Gln-Aib-Ala-Aib-Ser-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Valol[59]
TVB IIT. virens TV29–8Ac-Aib-Gly-Ala-Leu-Aib-Gln-Aib-Ala-Aib-Ser-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Valol[59]
TVB IVT. virens TV29–8Ac-Aib-Gly-Ala-Leu-Aib-Gln-Iva-Ala-Aib-Ser-Leu-Aib-Pro-Leu-Aib-Aib-Gln-Valol[59]
Ser: serine.
Table
Table 7. Analogs of longibrachins.
Table 7. Analogs of longibrachins.
LongibrachinStrainCompositionRef.
LG A IT. longbrachitum MMS151Ac-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln18-Gln-Pheol[64]
LG A Ⅱ T. longbrachitum MMS151Ac-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Iva-Gln18-Gln-Pheol[64]
LG A ⅢT. longbrachitum MMS151Ac-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln18-Gln-Pheol[64]
LG A ⅣT. longbrachitum MMS151Ac-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Iva-Gln18-Gln-Pheol[64]
LG B ⅡT. longbrachitum LCP-853431Ac-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu18-Gln-Pheol[65]
LG B ⅢT. longbrachitum LCP-853431Ac-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Iva-Glu18-Gln-Pheol[65]
Table
Table 8. Analogs of trichobrachins.
Table 8. Analogs of trichobrachins.
TrichobrachinStrainCompositionRef.
A I T. longibrachiatumAc-Aib-Asn-Leu-Leu-Aib-Pro-Leu-Aib-Aib-Pro-Leuol[69]
A IIT. longibrachiatumAc-Aib-Asn-Leu-Leu-Aib-Pro-Val-Leu-Aib-Pro-Valol[69]
A IIIT. longibrachiatumAc-Aib-Asn-Val-Leu-Aib-Pro-Leu-Leu-Aib-Pro-Valol[69]
A IVT. longibrachiatumAc-Aib-Asn-Leu-Val-Aib-Pro-Leu-Leu-Aib-Pro-Valol[69]
B IT. longibrachiatumAc-Aib-Asn-Leu-Leu-Aib-Pro-Val-Aib-Val-Pro-Leuol[69]
B IIT. longibrachiatumAc-Aib-Asn-Val-Leu-Aib-Pro-Leu-Aib-Val-Pro-Leuol[69]
B IIIT. longibrachiatumAc-Aib-Asn-Leu-Val-Aib-Pro-Leu-Aib-Val-Pro-Leuol[69]
B IVT. longibrachiatumAc-Aib-Asn-Leu-Leu-Aib-Pro-Leu-Aib-Val-Pro-Valol[69]
IT. parceramosum CBS 936.69Ac-Aib-Ala-Ala/Aib-Ala-Aib-Ala/Aib-Gln-Aib-Vxx-Aib-Gly-Leu-Aib-Pro-Vxx-Aib-Aib/Vxx-Gln-Gln[68]
ⅡT. parceramosum CBS 936.69Ac-Aib-Ala-Ala/Aib-Ala-Aib-Ala/Aib-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib/Vxx/Ala-Gln
Ac-Aib-Ala-Ala/Aib-Ala-Aib-Ala/Aib-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib/Vxx/Ala-Gln-Gln-Pheol		[68]
IIIT. parceramosum CBS 936.69Ac-Aib-Asn/Gln-Vxx/Lxx-Vxx/Lxx-Aib-Pro-Lxx-Vxx/Lxx-Aib-Pro-Lxxol/Valol[68]
Vxx: Val/Isovaline; Lxx: Leu/Ile; Lxxol: Leucinol/isoleucinol.
Table
Table 9. Analogs of trilongins
Table 9. Analogs of trilongins
TrilonginStrainCompositionRef.
AIV aT. longibrachiatumAc-Aib-Asn-Vxx-Vxx-Aib-Pro-Vxx-Lxx-Aib-Pro-Lxxol[77]
AIV bT. longibrachiatumAc-Aib-Asn-Vxx-Vxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Vxxol[77]
AIV cT. longibrachiatumAc-Aib-Asn-Vxx-Vxx-Aib-Pro-Lxx-Vxx-Aib-Pro-Lxxol[77]
AIII aT. longibrachiatumAc-Aib-Asn-Lxx-Vxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Vxxol[77]
AIII bT. longibrachiatumAc-Aib-Asn-Lxx-Vxx-Aib-Pro-Vxx-Lxx-Aib-Pro-Lxxol[77]
AIII cT. longibrachiatumAc-Aib-Asn-Vxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Vxxol[77]
AIII dT. longibrachiatumAc-Aib-Asn-Vxx-Lxx-Aib-Pro-Vxx-Lxx-Aib-Pro-Lxxol[77]
AII aT. longibrachiatumAc-Aib-Asn-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Vxxol[77]
AII bT. longibrachiatumAc-Aib-Asn-Lxx-Lxx-Aib-Pro-Lxx-Vxx-Aib-Pro-Lxxol[77]
AII cT. longibrachiatumAc-Aib-Asn-Lxx-Lxx-Aib-Pro-Vxx-Lxx-Aib-Pro-Lxxol[77]
AII dT. longibrachiatumAc-Aib-Asn-Lxx-Vxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[77]
AII eT. longibrachiatumAc-Aib-Asn-Vxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[77]
AIT. longibrachiatumAc-Aib-Asn-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[77]
A0T. longibrachiatumAc-Aib-Gln-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[77]
BIT. longibrachiatumAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[77]
BIIT. longibrachiatumAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[77]
BIIIT. longibrachiatumAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[77]
BIVT. longibrachiatumAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[77]
CIT. atroviride H1/226Ac-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib-Glu-Gln-Pheol[76]
CIIT. atroviride H1/226Ac-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Glu-Gln-Pheol[76]
CIIIT. atroviride H1/226Ac-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib-Glu-Gln-Pheol[76]
CIVT. atroviride H1/226Ac-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Glu-Gln-Pheol[76]
Lxx: Leu/Ile; Vxx: Val/Iva; Lxxol: Leuol/Ileol; Vxxol: Valol/Ivaol.
Table
Table 10. Analogs of trichokonins.
Table 10. Analogs of trichokonins.
TrichokoninStrainCompositionRef.
VIT. koningii OUDEMANS,
T. pseudokoningii SMF2		Ac-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln-Gln-Pheol[81,82]
IXT. koningii OUDEMANSAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Iva-Gin-Gln-Pheol[81]
IaT. koningii OUDEMANSAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Ala- Pro-Val-Aib-Aib-Gln-Gln-Pheol[81]
IbT. koningii OUDEMANSAc-Aib-Gly-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln-Gln-Pheol[81,84]
Table
Table 11. Analogs of alamethicins
Table 11. Analogs of alamethicins
AlamethicinComposition
F30Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu-Gln-Pheol
F50Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln-Gln-Pheol
Table
Table 12. Analogs of trichotoxins.
Table 12. Analogs of trichotoxins.
TrichotoxinStrainCompositionRef.
A-40T. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Glu-Aib-Aib-Aib-Ala-Aib-Aib-Pro-Leu-Aib-D-Iva-Gln-Valol[90]
A-40 IT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Ala-Ala-Aib-Aib-Pro-Leu-Aib-Aib-Glu-Valol[90]
A-40 IIT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Ala-Aib-Pro-Leu-Aib-Aib-Glu-Valol[90]
A-40 IIIT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Ala-Ala-Aib-Aib-Pro-Leu-Aib-D-Iva-Glu-Valol[90]
A-40 IVT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Aib-Aib-Pro-Leu-Aib-Aib-Glu-Valol[90]
A-40 VT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Aib-Aib-Pro-Leu-Aib-D-Iva-Glu-Valol[90]
A-40 VaT. viride NRRL 5242Ac-Aib-Ala-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Aib-Aib-Pro-Leu-Aib-Aib-Glu-Valol[90]
A-50 ET. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Ala-Aib-Pro-Leu-Aib-Aib-Gln-Valol[90]
A-50 FT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Ala-Ala-Ala-Aib-Pro-Leu-Aib-D-Iva-Gln-Valol[90]
A-50 GT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Ala-Aib-Pro-Leu-Aib-D-Iva-Gln-Valol[90]
A-50 HT. viride NRRL 5242Ac-Aib-Ala-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Ala-Aib-Pro-Leu-Aib-D-Iva-Gln-Valol[90]
A-50 IT. viride NRRL 5242Ac-Aib-Gly-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Aib-Aib-Pro-Leu-Aib-D-Iva-Gln-Valol[90]
A-50 JT. viride NRRL 5242Ac-Aib-Ala-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Ala-Aib-Aib-Pro-Leu-Aib-D-Iva-Gln-Valol[90]
Table
Table 13. Analogs of suzukacillins.
Table 13. Analogs of suzukacillins.
SuzukacillinStrainCompositionRef.
SZ-A1T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Vxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[94]
SZ-A2T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[94]
SZ-A3T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Vxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A4T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A5T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Lxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[94]
SZ-A6T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[94]
SZ-A7T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Lxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A8T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Aib-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A9T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[94]
SZ-A10aT. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Vxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A10bT. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A11aT. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Aib-Gln-Gln-Pheol[94]
SZ-A11bT. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A12T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Lxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-A13T. viride 63C-IAc-Aib-Ala-Aib-Ala-Aib-Ala-Gln-Aib-Lxx-Aib-Gly-Lxx-Aib-Pro-Vxx-Aib-Vxx-Gln-Gln-Pheol[94]
SZ-B1T. viride 63C-IAc-Aib-Gln-Vxx-Lxx-Aib-Pro-Lxx-Lxx-Ala-Pro[95]
SZ-B2T. viride 63C-IAc-Aib-Gln-Lxx-Vxx-Ala-Pro-Lxx-Lxx-Aib-Pro-Vxxol[95]
SZ-B3T. viride 63C-IAc-Aib-Asn-Vxx-Vxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B4T. viride 63C-IAc-Ala-Gln-Vxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B5T. viride 63C-IAc-Ala-Gln-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Vxxol[95]
SZ-B6T. viride 63C-IAc-Ala-Gln-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol -[95]
SZ-B7T. viride 63C-IAc-Ala-Gln-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Vxxol[95]
SZ-B8T. viride 63C-IAc-Aib-Asn-Vxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B9T. viride 63C-IAc-Aib-Gln-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Vxxol[95]
SZ-B10T. viride 63C-IAc-Aib-Gln-Lxx-Vxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B11T. viride 63C-IAc-Aib-Asn-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B12T. viride 63C-IAc-Aib-Gln-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B13T. viride 63C-IAc-Vxx-Gln-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B14T. viride 63C-IAc-Aib-Ala-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
SZ-B15T. viride 63C-IAc-Vxx-Glu-Lxx-Lxx-Aib-Pro-Lxx-Lxx-Aib-Pro-Lxxol[95]
Vxx: Val or Iva; Lxx: Leu or Ile (isovaline); Vxxol: Valol or Ivaol; Lxxol: Leuol or Ileol.
Table
Table 14. Analogs of hypomurocins.
Table 14. Analogs of hypomurocins.
HypomurocinStrainCompositionRef.
A-1H. muroiana IFO31288Ac-Aib-Gln-Val-Val-Aib-Pro-Leu-Leu-Aib-Pro-Leuol[96]
A-2H. muroiana IFO31288Ac-D-Iva-Gln-Val-Val-Aib-Pro-Leu-Leu-Aib-Pro-Leuol[96]
A-3H. muroiana IFO31288Ac-Aib-Gln-Val-Leu-Aib-Pro-Leu-Ile-Aib-Pro-Leuol[96]
A-4H. muroiana IFO31288Ac-Aib-Gln-Ile-Val-Aib-Pro-Leu-Leu-Aib-Pro-Leuol[96]
A-5H. muroiana IFO31288Ac-Aib-Gln-Ile-Ile-Aib-Pro-Leu-Leu-Aib-Pro-Leuol[96]
A-5aH. muroiana IFO31288Ac-Aib-Gln-Ile-Leu-Aib-Pro-Leu-Ile-Aib-Pro-Leuol[96]
B-1H. muroiana IFO31288Ac-Aib-Ser-Ala-Leu-Aib-Gln-Aib-Val-Aib-Gly-Aib-Aib-Pro-Leu-Aib-Aib-Gln-Valol[96]
B-2H. muroiana IFO31288Ac-Aib-Ser-Ala-Leu-Aib-Gln-Aib-Val-Aib-Gly-Aib-Aib-Pro-Leu-Aib-Aib-Gln-Leuol[96]
B-3aH. muroiana IFO31288Ac-Aib-Ala-Ala-Leu-Aib-Gln-Aib-Val-Aib-Gly-Aib-Aib-Pro-Leu-Aib-Aib-Gln-Valol[96]
B-3bH. muroiana IFO31288Ac-Aib-Ser-Ala-Leu-Aib-Gln-Iva-Val-Aib-Gly-Aib-Aib-Pro-Leu-Aib-Aib-Gln-Valol[96]
B-4H. muroiana IFO31288Ac-Aib-Ser-Ala-Leu-Aib-Gln-Aib-Val-Aib-Gly-Iva-Aib-Pro-Leu-Aib-Aib-Gln-Valol[96]
B-5 H. muroiana IFO31288Ac-Aib-Ser-Ala-Leu-Aib-Gln-Aib-Val-Aib-Gly-Iva-Aib-Pro-Leu-Aib-Aib-Gln-Leuol[96]
BT. harzianumAc-Aib-Ser-Ala-Leu-Ala-Gln-Aib-Val-Aib-Gly-Aib-Aib-Pro-Leu-Aib- Aib-Gln-Valol[59]
Table
Table 15. Analogs of atroviridins.
Table 15. Analogs of atroviridins.
AtroviridinComposition
AAc-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Gln-Gln-Pheol
BAc-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Iva-Gln-Gln-Pheol
CAc-Aib-Pro-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Iva-Gln-Gln-Pheol
Table
Table 16. Analogs of neoatroviridins.
Table 16. Analogs of neoatroviridins.
NeoatroviridinComposition
AAc-Aib-Gly-Ala-Leu-Aib-Gln-Aib-Leu-Aib-Gly-Iva-Aib-Pro-Leu-Aib-Aib-Gln-Leuol
BAc-Aib-Gly-Ala-Leu-Iva-Gln-Aib-Leu-Aib-Gly-Iva-Aib-Pro-Leu-Aib-Aib-Gln-Leuol
CAc-Aib-Gly-Ala-Leu-Aib-Gln-Iva-Leu-Aib-Gly-Iva-Aib-Pro-Leu-Aib-Aib-Gln-Leuol
DAc-Aib-Gly-Ala-Leu-Iva-Gln-Iva-Leu-Aib-Gly-Iva-Aib-Pro-Leu-Aib-Aib-Gln-Leuol
Table
Table 17. Analogs of peptaivirins.
Table 17. Analogs of peptaivirins.
PeptaivirinComposition
AAc-Phe-Aib-Ala-Aib-Iva-Leu-Gln-Gly-Aib-Aib-Ala-Ala-Aib-Pro-Iva-Aib-Aib-Gln-Trpol
BAc-Phe-Aib-Ser-Aib-Iva-Leu-Gln-Gly-Aib-Aib-Ala-Ala-Aib-Pro-Iva-Aib-Aib-Gln-Pheol

Share and Cite

MDPI and ACS Style

Niu, X.; Thaochan, N.; Hu, Q. Diversity of Linear Non-Ribosomal Peptide in Biocontrol Fungi. J. Fungi 2020, 6, 61. https://doi.org/10.3390/jof6020061

AMA Style

Niu X, Thaochan N, Hu Q. Diversity of Linear Non-Ribosomal Peptide in Biocontrol Fungi. Journal of Fungi. 2020; 6(2):61. https://doi.org/10.3390/jof6020061

Chicago/Turabian Style

Niu, Xiaoyan, Narit Thaochan, and Qiongbo Hu. 2020. "Diversity of Linear Non-Ribosomal Peptide in Biocontrol Fungi" Journal of Fungi 6, no. 2: 61. https://doi.org/10.3390/jof6020061

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop